Oral Glucose Tolerance Test (OGTT) for Schizophrenia

"Correct. According to clinicaltrials.gov, the trial that began on August 31st 2020 is still recruiting participants. Twenty individuals are needed across 6 different study centres for this initiative."

"This clinical trial is looking for patients between the ages of 18 to 59. There are 73 studies specifically recruiting individuals under 18, while 431 trials focus on those over 65 years old."

"The information hosted on clinicaltrials.gov confirms that this particular medical trial is currently enlisting participants, having been initially posted in August 2020 and most recently edited in December 2021."

"This medical trial seeks to enrol 20 volunteers with schizophrenia aged between 18 and 59. The key selection criteria is that they must have a Brief Negative Symptom Scale Score of at least 25, no psychotropic medication changes for one month prior to study enrollment (although other medications such as antidepressants are permissible), and finally a Mini Mental Status Examination Score of 24 or higher."

"This clinical trial's primary assessment will be a Change in Fasting Blood Glucose over the Baseline, Hours 1, 2, and 3 timespan. Secondary outcomes include Change in Resting State Scan - which involves correlating regional similarity with striatal seed region time series; Change in Effort-Expenditure for Rewards Task (EEfRT) Score - through calculating participants' choices between hard and easy tasks to obtain monetary rewards; plus a Change in neural response to anticipating and receiving monetary incentives assessed by Monetary Incentive Delay (MID) Task during fMRI neuroimaging."